Type 2 Diabetes Prevalence, Control and Management within Fiji,
Kiribati, Samoa, the Solomon Islands, Tonga, and Vanuatu: A Scoping
Review with a Systematic Approach

Timothy      Kuek
doi:10.2174/0115733998260306231025151814
Abstract

Background: Type 2 diabetes (T2D) causes significant morbidity and is disproportionately prevalent in Pacific Island Countries (PICs). The socio-political demographics of PICs are rapidly changing, and health services must adapt to match the needs of their population.
Objectives: The objective of this study was to review the literature published within the last 15 years relating to T2D prevalence, control, and management, with a specific focus on targetable areas for future funding and research projects.
Methods: This review was conducted using the PRISMA guidelines. Inclusion criteria were: discussion on T2D in the six PICs. Results were limited to those published between 1st January, 2006, and 27th July, 2023.
Results: A total of 6,640 publications were retrieved, and 110 met the inclusion criteria. Nineteen additional studies were identified through hand-searching. T2D prevalence differed between countries but was predicted to increase in the coming decades, with projections of up to 31.2% by 2030 in Tonga. Factors associated with T2D varied between countries, including Indian-Fijian ethnicity in Fiji and tuberculosis in Kiribati. Control was generally poor, with high rates of undiagnosed diabetes and microvascular complications. Epidemiological data was limited in some cases, as was information describing the structure and function of diabetes services.
Conclusion: The prevalence, control, and management of T2D varied between Fiji, Kiribati, Samoa, the Solomon Islands, Tonga, and Vanuatu. Significant gaps remain in the data describing these domains; however, there are clearly targetable areas for future research and diabetes management programs.
[1]
IDF. IDF Diabetes Atlas. 10th. Brussels, Belgium 2021.

[2]
Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes  2008; 26(2): 77-82.
 [http://dx.doi.org/10.2337/diaclin.26.2.77]

[3]
WHO. Division of Pacific Technical Support 2021. Available from: https://www.who.int/westernpacific/about/how-we-work/pacific-support

[4]
WHO. Pacific Island Countries. WHO 2013.

[5]
Arksey H, O’Malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Methodol  2005; 8(1): 19-32.
 [http://dx.doi.org/10.1080/1364557032000119616]

[6]
Micah DJ. Scoping Reviews (2020 version). JBI 2020.

[7]
Lin S, Naseri T, Linhart C, et al. Trends in diabetes and obesity in Samoa over 35 years, 1978–2013. Diabet Med  2017; 34(5): 654-61.
 [http://dx.doi.org/10.1111/dme.13197] [PMID: 27505623]

[8]
Lin S, Hufanga S, Linhart C, et al. Diabetes and obesity trends in Tonga Over 40 years. Asia Pac J Public Health  2016; 28(6): 475-85.
 [http://dx.doi.org/10.1177/1010539516645156] [PMID: 27122623]

[9]
Ampofo AG, Boateng EB. Beyond 2020: Modelling obesity and diabetes prevalence. Diabetes Res Clin Pract  2020; 167: 108362.
 [http://dx.doi.org/10.1016/j.diabres.2020.108362] [PMID: 32758618]

[10]
Hawley NL, McGarvey ST. Obesity and diabetes in Pacific Islanders: The current burden and the need for urgent action. Curr Diab Rep  2015; 15(5): 29.
 [http://dx.doi.org/10.1007/s11892-015-0594-5] [PMID: 25809458]

[11]
Nanditha A, Ma RCW, Ramachandran A, et al. Diabetes in Asia and the Pacific: Implications for the global epidemic. Diabetes Care  2016; 39(3): 472-85.
 [http://dx.doi.org/10.2337/dc15-1536] [PMID: 26908931]

[12]
Win Tin ST, Lee CMY, Colagiuri R. A profile of diabetes in pacific island countries and territories. Diabetes Res Clin Pract  2015; 107(2): 233-46.
 [http://dx.doi.org/10.1016/j.diabres.2014.10.010] [PMID: 25467624]

[13]
Hoy D, Roth A, Viney K, Souares Y, Lopez AD. Findings and implications of the global burden of disease 2010 study for the Pacific Islands. Prev Chronic Dis  2014; 11: 130344.
 [http://dx.doi.org/10.5888/pcd11.130344] [PMID: 24809361]

[14]
Brian G, Ramke J, Maher L, Page A, Szetu J. The prevalence of diabetes among adults aged 40 years and over in Fiji. N Z Med J  2010; 123(1327): 68-75.
 [PMID: 21358785]

[15]
Snowdon WK, Tukana I. NCD Risk Factors STEPS Report Suva, Fiji: Ministry of Health & Medical Services. Fiji: World Health Organization 2011.

[16]
Gyaneshwar R, Naidu S, Raban MZ, et al. Absolute cardiovascular risk in a Fiji medical zone. BMC Public Health  2015; 16(1): 128.
 [http://dx.doi.org/10.1186/s12889-016-2806-6] [PMID: 26861211]

[17]
Hawley NL, Minster RL, Weeks DE, et al. Prevalence of adiposity and associated cardiometabolic risk factors in the samoan genome wide association study. Am J Hum Biol  2014; 26(4): 491-501.
 [http://dx.doi.org/10.1002/ajhb.22553] [PMID: 24799123]

[18]
Morrell S, Lin S, Tukana I, et al. Diabetes incidence and projections from prevalence surveys in Fiji. Popul Health Metr  2016; 14(1): 45.
 [http://dx.doi.org/10.1186/s12963-016-0114-0] [PMID: 27905979]

[19]
Taylor R, Zimmet P, Naseri T, et al. Erroneous inflation of diabetes prevalence: Are there global implications? J Diabetes  2016; 8(6): 766-9.
 [http://dx.doi.org/10.1111/1753-0407.12447] [PMID: 27400903]

[20]
Samoa Samoa STEPS Survey 2013 Ministry of Health. Samoa: World Health Organization 2013.

[21]
Palu TP, Dan L, Riley L. Kingdom of Tonga NCD Risk Factors STEPS REPORT Ministry of Health. Tonga: World Health Organization 2014.

[22]
Styblo KM. Tuberculosis Surveillance Research Unit Report No. 1: The transmission of tubercle bacilli; its trend in a human population. Bull Int Union Tuberc  1969; 42.

[23]
Lin S, Naseri T, Linhart C, et al. Diabetes incidence and projections from prevalence surveys in Samoa over 1978–2013. Int J Public Health  2017; 62(6): 687-94.
 [http://dx.doi.org/10.1007/s00038-017-0961-x] [PMID: 28280865]

[24]
Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract  2014; 103(2): 150-60.
 [http://dx.doi.org/10.1016/j.diabres.2013.11.001] [PMID: 24300018]

[25]
Viney K, Cavanaugh J, Kienene T, et al. Tuberculosis and diabetes mellitus in the R epublic of K iribati: A case control study. Trop Med Int Health  2015; 20(5): 650-7.
 [http://dx.doi.org/10.1111/tmi.12462] [PMID: 25598275]

[26]
Brian G, Sikivou B, Fischer-Harder K, Szetu J, Qoqonokana MQ, Ramke J. Diabetic eye disease among adults in Fiji with previously undiagnosed diabetes. Clin Exp Ophthalmol  2011; 39(7): 682-90.
 [http://dx.doi.org/10.1111/j.1442-9071.2011.02533.x] [PMID: 22452686]

[27]
Morgan J. Country in Focus: Turning the tide of diabetes in Fiji. Lancet Diabetes Endocrinol  2015; 3(1): 15-6.
 [http://dx.doi.org/10.1016/S2213-8587(14)70240-2] [PMID: 25466524]

[28]
LaMonica LC, McGarvey ST, Rivara AC, et al. Cascades of diabetes and hypertension care in Samoa: Identi-fying gaps in the diagnosis, treatment, and control continuum: A cross sectional study. Lancet Regional Health : Western Pacific  2022; 18: 100313.
 [http://dx.doi.org/10.1016/j.lanwpc.2021.100313]

[29]
Brian G, Ramke J, Page A, Maher L, Szetu J, Qalo Qoqonokana M. The association of diabetes and BMI among Melanesian and Indian Fijians aged ≥ 40 years. Br J Nutr  2011; 105(10): 1539-45.
 [http://dx.doi.org/10.1017/S0007114510005258] [PMID: 21255475]

[30]
Ogle GD, Morrison MK, Silink M, Taito RS. Incidence and prevalence of diabetes in children aged <15 yr in Fiji, 2001-2012. Pediatr Diabetes  2016; 17(3): 222-6.
 [http://dx.doi.org/10.1111/pedi.12257] [PMID: 25597929]

[31]
FBoS. Population and Demographics Fiji: Fiji Bureau of Statistics. 2007. Available from: https://www.statsfiji.gov.fj/statistics/social-statistics/population-and-demographic-indicators.html

[32]
Kiribati Ministry of Health and Medical Services. Kiribati NCD Risk Factors STEPS REPORT 2015-2016 Ministry of Health and Medical Services Kiribati. World Health Organization 2016.

[33]
Cavanaugh J, Viney K, Kienene T, et al. Effect of diabetes on tuberculosis presentation and outcomes in Kiribati. Trop Med Int Health  2015; 20(5): 643-9.
 [http://dx.doi.org/10.1111/tmi.12468] [PMID: 25630576]

[34]
Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health  2019; 7(4): e448-60.
 [http://dx.doi.org/10.1016/S2214-109X(18)30487-X] [PMID: 30819531]

[35]
Viney K, Mills T, Harley D. Tuberculosis and diabetes mellitus: A dose-response relationship between the odds of tuberculosis and HbA1c. Int J Tuberc Lung Dis  2019; 23(10): 1055-9.
 [http://dx.doi.org/10.5588/ijtld.18.0657] [PMID: 31627769]

[36]
Hawley N, Menard H, Agha G, McGarvey S. Preliminary blood lipid, lipoprotein and glucose findings from the genome-wide association study of adiposity in samoans. Samoa Med J  2010; 2(2): 11-6.
 [PMID: 24634781]

[37]
Dibello JR, Baylin A, Viali S, Tuitele J, Bausserman L, Mcgarvey ST. Adiponectin and type 2 diabetes in Samoan adults. Am J Hum Biol  2009; 21(3): 389-91.
 [http://dx.doi.org/10.1002/ajhb.20858] [PMID: 19107905]

[38]
Myles S, Lea RA, Ohashi J, et al. Testing the thrifty gene hypothesis: The Gly482Ser variant in PPARGC1Ais associated with BMI in Tongans. BMC Med Genet  2011; 12(1): 10.
 [http://dx.doi.org/10.1186/1471-2350-12-10] [PMID: 21244673]

[39]
Lee CMY, Huxley RR, Woodward M, et al. Comparisons of metabolic syndrome definitions in four populations of the Asia Pacific region. Metab Syndr Relat Disord  2008; 6(1): 37-46.
 [http://dx.doi.org/10.1089/met.2007.0024] [PMID: 18370835]

[40]
Craig P, Colagiuri S, Hussain Z, Palu T. Identifying cut points in anthropometric indexes for predicting previously undiagnosed diabetes and cardiovascular risk factors in the Tongan population. Obes Res Clin Pract  2007; 1(1): 17-25.
 [http://dx.doi.org/10.1016/j.orcp.2006.08.001] [PMID: 24351428]

[41]
Win Tin ST, Kenilorea G, Gadabu E, Tasserei J, Colagiuri R. The prevalence of diabetes complications and associated risk factors in Pacific Islands countries. Diabetes Res Clin Pract  2014; 103(1): 114-8.
 [http://dx.doi.org/10.1016/j.diabres.2013.09.017] [PMID: 24280592]

[42]
Win Tin ST, Laesango N, Gadabu E, Colagiuri R. Comparing metabolic control and complications in type 2 diabetes in two Pacific Islands at baseline and following diabetes care intervention. J Clin Transl Endocrinol  2016; 4: 32-7.
 [http://dx.doi.org/10.1016/j.jcte.2016.03.001] [PMID: 29159128]

[43]
Yanagawa M, Morishita F, Oh KH, Rahevar K, Islam TA, Yadav S. Epidemiology of tuberculosis in the Pacific island countries and areas, 2000-2020. Western pac  2023; 14(1): 1-12.

[44]
Hoy D, Kienene T, Reiher B, et al. Battling tuberculosis in an island context with a high burden of communicable and non-communicable diseases: Epidemiology, progress, and lessons learned in Kiribati, 2000 to 2012. Int J Infect Dis  2015; 30: 135-41.
 [http://dx.doi.org/10.1016/j.ijid.2014.11.025] [PMID: 25455798]

[45]
Gounder S, Harries AD. Screening tuberculosis patients for diabetes mellitus in Fiji: notes from the field [Short communication]. Public Health Action  2012; 2(4): 145-7.
 [http://dx.doi.org/10.5588/pha.12.0058] [PMID: 26392974]

[46]
Neel JV. Diabetes mellitus: A “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet  1962; 14(4): 353-62.
 [PMID: 13937884]

[47]
Gosling AL, Buckley HR, Matisoo-Smith E, Merriman TR. Pacific populations, metabolic disease and ‘Just-So Stories’: A critique of the ‘Thrifty Genotype’ hypothesis in oceania. Ann Hum Genet  2015; 79(6): 470-80.
 [http://dx.doi.org/10.1111/ahg.12132] [PMID: 26420513]

[48]
Minster RL, Hawley NL, Su CT, et al. A thrifty variant in CREBRF strongly influences body mass index in Samoans. Nat Genet  2016; 48(9): 1049-54.
 [http://dx.doi.org/10.1038/ng.3620] [PMID: 27455349]

[49]
Hawley NL, Duckham RL, Carlson JC, et al. The protective effect of rs373863828 on type 2 diabetes does not operate through a body composition pathway in adult Samoans. Obesity  2022; 30(12): 2468-76.
 [http://dx.doi.org/10.1002/oby.23559] [PMID: 36284436]

[50]
Russell EM, Carlson JC, Krishnan M, et al. CREBRF missense variant rs373863828 has both direct and indirect effects on type 2 diabetes and fasting glucose in polynesian peoples living in samoa and aotearoa New Zealand BMJ open diabetes res  2022; 10(1): 02.
 [http://dx.doi.org/10.1136/bmjdrc-2021-002275]

[51]
Colagiuri R. Building capacity to reduce diabetes complications in the Pacific: The Vanuatu experience so far. Pract Diabetes Int  2006; 23(8): 343-6.
 [http://dx.doi.org/10.1002/pdi.1006]

[52]
Morrell S, Taylor R, Nand D, Rao C. Changes in proportional mortality from diabetes and circulatory disease in Mauritius and Fiji: Possible effects of coding and certification. BMC Public Health  2019; 19(1): 481.
 [http://dx.doi.org/10.1186/s12889-019-6748-7] [PMID: 31046741]

[53]
Carter K, Hufanga S, Rao C, et al. Causes of death in Tonga: quality of certification and implications for statistics. Popul Health Metr  2012; 10(1): 4.
 [http://dx.doi.org/10.1186/1478-7954-10-4] [PMID: 22390221]

[54]
Carter K, Tovu V, Langati JT, et al. Causes of death in Vanuatu. Popul Health Metr  2016; 14(1): 7.
 [http://dx.doi.org/10.1186/s12963-016-0074-4] [PMID: 26981050]

[55]
Taylor R, Lin S, Linhart C, Morrell S. Overview of trends in cardiovascular and diabetes risk factors in Fiji. Ann Hum Biol  2018; 45(3): 188-201.
 [http://dx.doi.org/10.1080/03014460.2018.1465122] [PMID: 29877150]

[56]
Win Tin ST, Iro G, Gadabu E, Colagiuri R. Counting the cost of diabetes in the Solomon Islands and Nauru. PLoS One  2015; 10(12): e0145603.
 [http://dx.doi.org/10.1371/journal.pone.0145603] [PMID: 26698575]

[57]
Falconer DG, Buckley A, Colagiuri R. Counting the cost of type 2 diabetes in Vanuatu. Diabetes Res Clin Pract  2010; 87(1): 92-7.
 [http://dx.doi.org/10.1016/j.diabres.2009.09.022] [PMID: 19875191]

[58]
Kumar L, Mohammadnezhad M. Health care workers’ perceptions on factors affecting diabetes self-management among Type 2 Diabetes Mellitus patients in Fiji: A qualitative study. Front Public Health  2022; 10: 779266.
 [http://dx.doi.org/10.3389/fpubh.2022.779266] [PMID: 35444994]

[59]
Romakin P, Mohammadnezhad M. Healthcare Providers’ perception of healthcare system factors associated with poor glycemic control among Type 2 Diabetes patients in fiji. Rev Diabet Stud  2019; 15(1): 49-57.
 [http://dx.doi.org/10.1900/RDS.2019.15.49] [PMID: 31380887]

[60]
Ranuve MS, Mohammadnezhad M. Healthcare workers’ perceptions on diabetic foot ulcers (DFU) and foot care in Fiji: A qualitative study. BMJ Open  2022; 12(8): e060896.
 [http://dx.doi.org/10.1136/bmjopen-2022-060896] [PMID: 35918113]

[61]
Damato EM, Murray N, Szetu J, Sikivou BT, Emma S, McGhee CNJ. Sight threatening diabetic retinopathy at presentation to screening services in Fiji. Ophthalmic Epidemiol  2014; 21(5): 318-26.
 [http://dx.doi.org/10.3109/09286586.2014.949781] [PMID: 25157913]

[62]
Bhikoo R, Murray N, Sikivou B, Emma S, McGhee C. Demographic features and visual outcomes of patients presenting to diabetic photo screening and treated for sight threatening retinopathy in Fiji. Int J Ophthalmol  2017; 10(5): 790-5.
 [PMID: 28546939]

[63]
Phillips T, Ravuvu A, McMichael C, et al. Nutrition policy making in Fiji: Working in and around neoliberalisation in the Global South. Crit Public Health  2021; 31(3): 316-26.
 [http://dx.doi.org/10.1080/09581596.2019.1680805]

[64]
Kumar L, Mohammadnezhad M. Perceptions of patients on factors affecting diabetes self-management among type 2 diabetes mellitus (T2DM) patients in Fiji: A qualitative study. Heliyon  2022; 8(6): e09728.
 [http://dx.doi.org/10.1016/j.heliyon.2022.e09728] [PMID: 35756103]

[65]
Ibrahim AM, Lawrence S. Improving Diabetes Care: A fijian diabetes service improvement study. int  2022; 2022: 9486679.

[66]
Zibran MA, Mohammadnezhad M. Management of Type 2 diabetes and chronic kidney disease in Fiji in 2018: Knowledge, attitude, and practice of patients. Rev Diabet Stud  2019; 15(1): 26-34.
 [http://dx.doi.org/10.1900/RDS.2019.15.26] [PMID: 31132078]

[67]
Romakin P, Mohammadnezhad M. Patient related factors associated with poor glycaemic control among patients with type 2 diabetes mellitus. Aust J Gen Pract  2019; 48(8): 557-63.
 [http://dx.doi.org/10.31128/AJGP-02-19-4859] [PMID: 31370132]

[68]
WHO. Western Pacific Country Health Information Profiles 2011 Revision. World Health Organization 2011.

[69]
Ofanoa M, Tekeraoi R, Dalmia P, et al. Patient perspectives of diabetes and diabetic retinopathy services in Kiribati: A qualitative study. Asia Pac J Public Health  2020; 1010539520977313.
 [PMID: 33287551]

[70]
Baghirov R, Ah-Ching J, Bollars C. Achieving UHC in samoa through revitalizing PHC and reinvigorating the role of village women groups. Health Syst Reform  2019; 5(1): 78-82.
 [http://dx.doi.org/10.1080/23288604.2018.1539062] [PMID: 30924751]

[71]
Bollars C, Sørensen K, de Vries N, Meertens R. Exploring health literacy in relation to noncommunicable diseases in samoa: A qualitative study. BMC Public Health  2019; 19(1): 1151.
 [http://dx.doi.org/10.1186/s12889-019-7474-x] [PMID: 31438907]

[72]
Hardin J. “Healing is a Done Deal”: Temporality and metabolic healing among evangelical Christians in Samoa. Med Anthropol  2016; 35(2): 105-18.
 [http://dx.doi.org/10.1080/01459740.2015.1092143] [PMID: 26436693]

[73]
Taumoepeau J, Knight-Agarwal CR, Tu’i EAP, Jani R, Osuagwu UL, Simmons D. Living with type 2 diabetes mellitus in the Kingdom of Tonga: A qualitative investigation of the barriers and enablers to lifestyle management. BMC Public Health  2021; 21(1): 1307.
 [http://dx.doi.org/10.1186/s12889-021-11391-7] [PMID: 34217248]

[74]
Win Tin ST, Gadabu E, Iro G, Tasserei J, Colagiuri R. Diabetes related amputations in Pacific Islands countries: A root cause analysis of precipitating events. Diabetes Res Clin Pract  2013; 100(2): 230-4.
 [http://dx.doi.org/10.1016/j.diabres.2013.03.012] [PMID: 23523284]

[75]
Bezo BH, Huang YT, Lin CC. Factors influencing self‐management behaviours among patients with type 2 diabetes mellitus in the Solomon Islands. J Clin Nurs  2020; 29(5-6): 852-62.
 [http://dx.doi.org/10.1111/jocn.15139] [PMID: 31823422]

[76]
Ofanoa M, Aitip B, Ram K, et al. A qualitative study of patient perspectives of diabetes and diabetic retinopathy services in Vanuatu. Health Promot J Austr 2021.
 [PMID: 33743544]

[77]
Elliott LM, Taylor J. Community perceptions of the determinants of diabetes in Peri-Urban vanuatu. Asia Pac J Public Health  2021; 33(6-7): 734-9.
 [http://dx.doi.org/10.1177/10105395211005924] [PMID: 33797296]

[78]
Watters DAK, Ewing H, McCaig E. Three phases of the pacific islands project (1995–2010). ANZ J Surg  2012; 82(5): 318-24.
 [http://dx.doi.org/10.1111/j.1445-2197.2012.06036.x] [PMID: 22507204]

[79]
Gardner K, Bailie R, Si D, et al. Reorienting primary health care for addressing chronic conditions in remote Australia and the South Pacific: Review of evidence and lessons from an innovative quality improvement process. Aust J Rural Health  2011; 19(3): 111-7.
 [http://dx.doi.org/10.1111/j.1440-1584.2010.01181.x] [PMID: 21605223]

[80]
Khan S, Mohammadnezhad M, Ratu A, et al. Patterns and risk factors associated with index lower extremity amputations (LEA) among type 2 diabetes mellitus (T2DM) patients in Fiji. Prim Care Diabetes  2021; 15(6): 1012-8.
 [http://dx.doi.org/10.1016/j.pcd.2021.07.007] [PMID: 34284950]

[81]
Ram S, Mohammadnezhad M, Ram K, Dalmia P, Pal M. Impact of diabetic retinopathy awareness training on community health workers’ knowledge and referral practices in Fiji: A qualitative study. Rural Remote Health  2022; 22(2): 6976.
 [http://dx.doi.org/10.22605/RRH6976] [PMID: 35684971]

[82]
McLennan AK, Ulijaszek SJ. An anthropological insight into the Pacific island diabetes crisis and its clinical implications. Diabetes Manag  2015; 5(3): 143-5.
 [http://dx.doi.org/10.2217/dmt.15.4]

[83]
Qoqonokana MQ, Brian G, Ramke J, Garcia J, Szetu J. Diabetic retinopathy in a hospital eye clinic population in Honiara, Solomon Islands. Clin Exp Ophthalmol  2010; 38(9): 862-6.
 [http://dx.doi.org/10.1111/j.1442-9071.2010.02356.x] [PMID: 20572820]

[84]
Elliott L, Taylor J. Medical pluralism, sorcery belief and health seeking in Vanuatu: A quantitative and descriptive study. Health Promot Int  2021; 36(3): 722-30.
 [http://dx.doi.org/10.1093/heapro/daaa079] [PMID: 33025023]

[85]
Mala P, Khan GA, Gopalan R, Gedefaw D, Soapi K. Fijian medicinal plants and their role in the prevention of Type 2 diabetes mellitus. Biosci Rep  2022; 42(11): BSR20220461.
 [http://dx.doi.org/10.1042/BSR20220461] [PMID: 36149310]

[86]
Siaki LA. Translating questions for use with Samoan adults: Lessons learned. J Transcult Nurs  2011; 22(2): 122-8.
 [http://dx.doi.org/10.1177/1043659610395766] [PMID: 21311087]

[87]
Kumar K, Snowdon W, Ram S, et al. Descriptive analysis of diabetes-related amputations at the Colonial War Memorial Hospital, Fiji, 2010–2012. Public Health Action  2014; 4(3): 155-8.
 [http://dx.doi.org/10.5588/pha.14.0026] [PMID: 26400802]

[88]
Qio VF. Four year retrospective report On Fiji’s diabetic footcare program. IDF Congress. 

[89]
Sharma NK. Effects of a longitudinal peer to peer support group foot care intervention program in a prospective cohort of patients with diabetes mellitus.  Endocrine and Metabolic Science 2021; p. 4.

[90]
Brian G, Fischer-Harder K, Sikivou B, Qoqonokana MQ, Szetu J, Ramke J. Diabetic eye disease among adults in Fiji with self‐reported diabetes. Clin Exp Ophthalmol  2010; 38(9): 867-74.
 [http://dx.doi.org/10.1111/j.1442-9071.2010.02361.x] [PMID: 20572814]

[91]
Jeganathan VSE, Langford T, Sefo LAC, Hewitt AW, Verma N. Screening for diabetic eye disease among samoan adults: A pilot study. Ophthalmol Ther  2017; 6(1): 187-94.
 [http://dx.doi.org/10.1007/s40123-017-0092-8] [PMID: 28516404]

[92]
Smith TST, Szetu J, Bourne RRA. The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu. Br J Ophthalmol  2007; 91(4): 415-9.
 [http://dx.doi.org/10.1136/bjo.2006.104174] [PMID: 17077115]

[93]
Ramke J, Brian G, Du Toit R. Eye disease and care at hospital clinics in Cook Islands, Fiji, Samoa and Tonga. Clin Exp Ophthalmol  2007; 35(7): 627-34.
 [http://dx.doi.org/10.1111/j.1442-9071.2007.01556.x] [PMID: 17894682]

[94]
Nakhate S, Walker M, Walker J. Using basic technology to screen for diabetic retinopathy in Fiji. Community Eye Health  2008; 21(66): 33.
 [PMID: 18670602]

[95]
Ram S, Mohammadnezhad M, Ram K, Prasad K, Pal M, Dalmia P. Increasing and sustaining diabetic retinopathy screening in Fiji by leveraging community health workers (CHWs) services: A qualitative study. Heliyon  2022; 8(11): e11379.
 [http://dx.doi.org/10.1016/j.heliyon.2022.e11379] [PMID: 36387573]

[96]
LaMonica LC, Hawley NL, Bhardwaj MK, Naseri T, Reupena MS, Ramsey DJ. Nonmydriatic fundus photography in a high risk population of Samoans with diabetes: The Soifua Manuia eye screening program. Clin Exp Ophthalmol  2019; 47(7): 954-6.
 [http://dx.doi.org/10.1111/ceo.13527] [PMID: 31034672]

[97]
Williams C, Szetu JL, Ramke J, Palagyi A, Du Toit R, Brian G. Evaluation of the first 5 years of a national eye health programme in Vanuatu. Clin Exp Ophthalmol  2008; 36(2): 162-7.
 [http://dx.doi.org/10.1111/j.1442-9071.2008.01685.x] [PMID: 18352874]

[98]
Caceres J, Zhang Y, Boe L, et al. Diabetic retinopathy screening using a portable retinal camera in Vanuatu. medRxiv 2022.
 [http://dx.doi.org/10.1101/2022.05.25.22275597]

[99]
Lees J, McCool J, Woodward A. Eye health outreach services in the Pacific Islands region: An updated profile. N Z Med J  2015; 128(1420): 25-33.
 [PMID: 26367510]

[100]
Krishnan A, Chandra Y, Malani J, Jesudason S, Sen S, Ritchie AG. End stage kidney disease in Fiji. Intern Med J  2019; 49(4): 461-6.
 [http://dx.doi.org/10.1111/imj.14108] [PMID: 30230153]

[101]
Tafuna’i M, Matalavea B, Voss D, et al. Kidney failure in Samoa  2020; 5: 100058.
 [http://dx.doi.org/10.1016/j.lanwpc.2020.100058]

[102]
Aitaoto NR, Haemodialysis K. Samoa: A model for other Pacific Nations.  The Lancet Regional Health: Western Pacific 2021; p. 6.

[103]
Lee CM, Huxley RR, Lam TH, et al. Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions. Asia Pac J Clin Nutr  2007; 16(1): 187-92.
 [PMID: 17215197]

[104]
Matoto V, Viney K, Roseveare C, Colaguiri R, Marais BJ. Burden and spectrum of disease in people with diabetes in Tonga. Public Health Action  2014; 4(1)(1): 44-9.
 [http://dx.doi.org/10.5588/pha.13.0080] [PMID: 26477287]

[105]
Sahal Estimé M, Lutz B, Strobel F. Trade as a structural driver of dietary risk factors for noncommunicable diseases in the Pacific: an analysis of household income and expenditure survey data. Global Health  2014; 10(1): 48.
 [http://dx.doi.org/10.1186/1744-8603-10-48] [PMID: 24927626]

[106]
Pak N, Mcdonald AM, McKenzie J, Tukuitonga C. Soft drink consumption in Pacific Island countries and territories: A review of trade data. Pac Health Dialog  2014; 20(1): 59-66.
 [PMID: 25928998]

[107]
Lameko V. Does samoa have adequate policies to reduce obesity and obesity-related disease? Cureus  2022; 14(3): e23239.
 [http://dx.doi.org/10.7759/cureus.23239] [PMID: 35449683]

[108]
Lyons G, Dean G, Tongaiaba R, et al. Macro- and micronutrients from traditional food plants could improve nutrition and reduce non-communicable diseases of Islanders on Atolls in the South Pacific. Plants  2020; 9(8): 942.
 [http://dx.doi.org/10.3390/plants9080942] [PMID: 32722347]

[109]
Hawley NL, Wier LM, Cash HL, Viali S, Tuitele J, McGarvey ST. Modernization and cardiometabolic risk in Samoan adolescents. Am J Hum Biol  2012; 24(4): 551-7.
 [http://dx.doi.org/10.1002/ajhb.22269] [PMID: 22430949]

[110]
Furusawa T, Furusawa H, Eddie R, Tuni M, Pitakaka F, Aswani S. Communicable and non-communicable diseases in the Solomon Islands villages during recovery from a massive earthquake in April 2007. N Z Med J  2011; 124(1333): 17-28.
 [PMID: 21750591]

[111]
Tin STW, Na’ati E, Bertrand S, et al. Assessing the status of diabetes associations in the pacific: A starting point for strengthening associations to manage diabetes. Hawaii J Health Soc Welf  2021; 80(3): 68-72.
 [PMID: 33718880]

[112]
Szmedra P, Sharma KL, Rozmus CL. Health promoting behavior among chronically ill Pacificans living with non-communicable disease in Fiji, Nauru, and Kiribati. Pac Health Dialog  2009; 15(2): 55-65.
 [PMID: 20443522]

[113]
Szmedra P, Chand A, Prasad M, DeTitta T, Rozmus C. Using community theater to improve diabetes education in Fiji. Int J Diabetes Dev Ctries  2018; 38(4): 502-8.
 [http://dx.doi.org/10.1007/s13410-018-0610-9]

[114]
Creaton A, Holt J. Health promotion in Fiji: Is it feasible in the emergency department? Emerg Med Australas  2017; 29(6): 686-91.
 [http://dx.doi.org/10.1111/1742-6723.12846] [PMID: 28815974]

[115]
Kent LM, Reierson P, Morton DP. ‘Live more’: Study protocol for a community-based lifestyle education program addressing non-communicable diseases in low-literacy areas of the South Pacific. BMC Public Health  2015; 15(1): 1221.
 [http://dx.doi.org/10.1186/s12889-015-2560-1] [PMID: 26652606]

[116]
Thompson R. Pacific Islands NCDs. New Caledonia: Secretariat of the Pacific Community 2010.

[117]
Projects Bagsværd WDF. WDF. Projects Bagsværd, Denmark: World Diabetes Founda-tion.  Available from: https://www.worlddiabetesfoundation.org/projects/search?search_api_views_fulltext=&field_project_status=All&field_geo_region=Australia&field_services=All

[118]
Cornelius MD, Pryor M, Saketa S. STEPS 2002. Fiji: World Health Organization, Ministry of Health, Fiji School of Medicine, Menzies Centre for Population Health, University of Tasmania, AusAID 2002.

[119]
IDF. IDF Diabetes Atlas. 6th. Brussels, Belgium 2011.

[120]
Snowdon WK, Tukana I. I NCD Risk Factors STEPS Report STEPS Suva, Fiji: Ministry of Health & Medical Services. Fiji: World Health Organization 2011.

[121]
IDF. IDF Diabetes Atlas. 10th. Brussels, Belgium 2021.

[122]
Kiribati Ministry of Health and Medical Services. WHO Kiribati NCD Risk Factors STEPS REPORT 2015-2016 STEPS Report: Ministry of Health and Medical Services Kiribati. World Health Organization 2016.

[123]
MoH. Samoa Samoa STEPS Survey WHO STEPS Chronic Disease RIsk Factor Surveillance: Ministry of Health. Samoa: World Health Organization 2002.

[124]
MoH. Samoa Samoa STEPS Survey 2013 STEPS: Ministry of Health. Samoa: World Health Organization 2013.

[125]
Hawley NL, Minster RL, Weeks DE, et al. Prevalence of adiposity and associated cardiometabolic risk factors in the samoan genome‐wide association study. Am J Hum Biol  2014; 26(4): 491-501.
 [http://dx.doi.org/10.1002/ajhb.22553] [PMID: 24799123]

[126]
MoH. Solomon Islands Solomon Islands STEPS Survey 2006: Ministry of Health. Solomon Islands: World Health Organization 2006.

[127]
Palu TP, Dan L, Riley L. Kingdom of Tonga NCD Risk Factors STEPS REPORT: Ministry of Health. Tonga: World Health Organization 2014.

[128]
Tekiteki CP, Dan L, Riley L, et al. Kingdom of Tonga NCD Risk Factors STEPS REPORT 2014 STEPS REPORT Suva, Fiji: Ministry of Health. Tonga: World Health Organization 2014.

[129]
Vanuatu MoH. Vanuatu STEPS Survey 2011 Fact Sheet: Ministry of Health. Vanuatu: World Health Organization 2011.
Rights & Permissions Print Cite
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/0115733998260306231025151814	Print ISSN 1573-3998
Publisher Name Bentham Science Publisher	Online ISSN 1875-6417
Current Diabetes Reviews

Type 2 Diabetes Prevalence, Control and Management within Fiji, Kiribati, Samoa, the Solomon Islands, Tonga, and Vanuatu: A Scoping Review with a Systematic Approach

Abstract Play Pause

Related Journals

Related Books

Abstract
